Get started
MERCK & CO., INCMERCK & CO., INCMERCK & CO., INC

MERCK & CO., INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

MRK chart


Full chart

Key facts today


Merck & Co. is acquiring Verona Pharma for $10 billion to diversify its drug portfolio as Keytruda's patent expires in 2028. Verona's Ohtuvayre shows strong sales potential.
Merck & Co. has started Phase 3 trials for its monthly HIV prevention pill, MK-8527, assessing safety and efficacy in high-risk individuals across 16 countries, with enrollment starting in August.
Analyze the impactAnalyze the impact

MRK upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.91 T‬ MXN
Dividend yield (indicated)
3.89%
Price to earnings Ratio (TTM)
12.22
Basic EPS (TTM)
141.21 MXN
Net income (FY)
‪356.88 B‬ MXN
Revenue (FY)
‪1.33 T‬ MXN
Shares float
‪2.51 B‬
Beta (1Y)
0.39

Employees


Employees (FY)
‪75 K‬
Change (1Y)
‪+3 K‬ +4.17%
Revenue / Employee (1Y)
‪17.78 M‬ MXN
Net income / Employee (1Y)
‪4.76 M‬ MXN

About Merck & Company, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert M. Davis
Website
merck.com
Headquarters
Rahway
Founded
1891
FIGI
BBG00JX0P1C8
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Check out other big names from the same industry as MRK.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

MRK news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

MRK highest yielding bonds


MRK5002693
Merck & Co., Inc. 2.45% 24-JUN-2050
Yield to maturity
7.34%
Maturity date
Jun 24, 2050
MRK5319197
Merck & Co., Inc. 2.9% 10-DEC-2061
Yield to maturity
7.21%
Maturity date
Dec 10, 2061
US58933YBF1
MERCK & CO. 21/51
Yield to maturity
7.04%
Maturity date
Dec 10, 2051
US58933YBA2
MERCK & CO. 20/40
Yield to maturity
6.50%
Maturity date
Jun 24, 2040
US58933YAT2
MERCK CO. 2045
Yield to maturity
6.39%
Maturity date
Feb 10, 2045
MRK4806294
Merck & Co., Inc. 4.0% 07-MAR-2049
Yield to maturity
6.28%
Maturity date
Mar 7, 2049
MRK3900816
Merck & Co., Inc. 3.6% 15-SEP-2042
Yield to maturity
6.18%
Maturity date
Sep 15, 2042
MRK5584756
Merck & Co., Inc. 5.15% 17-MAY-2063
Yield to maturity
6.04%
Maturity date
May 17, 2063
US58933YAJ4
MERCK CO. 13/43
Yield to maturity
6.01%
Maturity date
May 18, 2043
MRK5584755
Merck & Co., Inc. 5.0% 17-MAY-2053
Yield to maturity
5.96%
Maturity date
May 17, 2053
MRK5584925
Merck & Co., Inc. 4.9% 17-MAY-2044
Yield to maturity
5.82%
Maturity date
May 17, 2044

See all MRK bonds 

Sparks


Curated watchlists where MRK is featured.

See all sparks 

Frequently Asked Questions


The current price of MRK is 1,565.00 MXN — it has decreased by −0.55% in the past 24 hours. Watch MERCK & CO., INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange MERCK & CO., INC stocks are traded under the ticker MRK.
MRK stock has risen by 0.80% compared to the previous week, the month change is a 0.49% rise, over the last year MERCK & CO., INC has showed a −31.90% decrease.
We've gathered analysts' opinions on MERCK & CO., INC future price: according to them, MRK price has a max estimate of 2,630.60 MXN and a min estimate of 1,529.85 MXN. Watch MRK chart and read a more detailed MERCK & CO., INC stock forecast: see what analysts think of MERCK & CO., INC and suggest that you do with its stocks.
MRK stock is 1.16% volatile and has beta coefficient of 0.39. Track MERCK & CO., INC stock price on the chart and check out the list of the most volatile stocks — is MERCK & CO., INC there?
Today MERCK & CO., INC has the market capitalization of ‪3.91 T‬, it has decreased by −2.15% over the last week.
Yes, you can track MERCK & CO., INC financials in yearly and quarterly reports right on TradingView.
MERCK & CO., INC is going to release the next earnings report on Jul 29, 2025. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are 45.48 MXN per share, whereas the estimation was 43.69 MXN resulting in a 4.10% surprise. The estimated earnings for the next quarter are 38.01 MXN per share. See more details about MERCK & CO., INC earnings.
MERCK & CO., INC revenue for the last quarter amounts to ‪318.15 B‬ MXN, despite the estimated figure of ‪314.25 B‬ MXN. In the next quarter, revenue is expected to reach ‪297.59 B‬ MXN.
MRK net income for the last quarter is ‪104.05 B‬ MXN, while the quarter before that showed ‪78.04 B‬ MXN of net income which accounts for 33.34% change. Track more MERCK & CO., INC financial stats to get the full picture.
Yes, MRK dividends are paid quarterly. The last dividend per share was 15.33 MXN. As of today, Dividend Yield (TTM)% is 3.84%. Tracking MERCK & CO., INC dividends might help you take more informed decisions.
MERCK & CO., INC dividend yield was 3.14% in 2024, and payout ratio reached 46.32%. The year before the numbers were 2.72% and ‪2.07 K‬% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 15, 2025, the company has ‪75 K‬ employees. See our rating of the largest employees — is MERCK & CO., INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MERCK & CO., INC EBITDA is ‪546.68 B‬ MXN, and current EBITDA margin is 39.30%. See more stats in MERCK & CO., INC financial statements.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MERCK & CO., INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MERCK & CO., INC technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MERCK & CO., INC stock shows the sell signal. See more of MERCK & CO., INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.